Investigation Launched into Treace Medical Concepts Following Major Stock Drop

Glancy Prongay & Murray LLP (“GPM”), a prominent national shareholder rights law firm, has initiated an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) TMCI investors. This inquiry focuses on the Company’s potential violations of federal securities laws.

If you have suffered financial losses related to your Treace investments or are interested in pursuing claims under federal securities laws, you can provide your contact details at www.glancylaw.com/cases/Treace-Medical-Concepts-Inc/. Additionally, you may reach out to Charles H. Linehan from GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com for more information about your rights.

On May 7, 2024, Treace revealed its financial results for the first quarter of 2024 and downgraded its full-year guidance by approximately $20 million. This revision was attributed to “increased use of MIS Osteotomy solutions and more competition from knockoffs of [the Company’s] Lapiplasty products.”

Following this news, Treace’s stock price plummeted by $6.95, or 62.5%, closing at $4.17 per share on May 8, 2024, causing significant distress for investors.

For further updates, you can follow us on LinkedIn, Twitter, or Facebook.

Whistleblower Notice: Individuals who possess non-public information related to Treace should explore their options to assist the investigation or participate in the SEC Whistleblower Program. This program offers rewards of up to 30 percent for whistleblowers providing original information leading to successful SEC recoveries. For more details, contact Charles H. Linehan at 310-201-9150 or 888-773-9224, or email shareholders@glancylaw.com.

About GPM

Glancy Prongay & Murray LLP is a leading law firm representing investors and consumers in securities litigation and various complex class action cases. Consistently ranked in ISS Securities Class Action Services’ annual SCAS Top 50 Report, GPM achieved a top five ranking for the number of securities class action settlements in 2018, and a top six ranking for the total dollar amount of those settlements. With nearly 40 attorneys across four offices nationwide, GPM has successfully recovered billions of dollars for investors and consumers, addressing an array of corporate misconduct cases—ranging from financial discrepancies to violations of FDA regulations.

This press release may be deemed Attorney Advertising in certain jurisdictions according to applicable laws and ethical standards.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241101090303/en/